Acute Pediatric Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Rhombencephalitis With Multifocal Brain

Ruilin Wang1, Jessica N Smock1, Anusri Pakhare2

  • 1Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.

Cureus
|March 30, 2026
PubMed

Insights

Autoimmune rhombencephalitis, including myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), requires prompt treatment. Early treatment based on clinical and imaging findings is crucial for children with MOGAD, even with delayed antibody results.

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Rhombencephalitis is a rare brainstem inflammation with infectious and autoimmune causes.
  • Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an increasingly recognized autoimmune etiology, particularly in children.
  • Pediatric rhombencephalitis often presents with diverse neurological symptoms.